pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
  1. pharmadog
  2. ›drugs
  3. ›Chewtadzy
drug
save

Chewtadzy

Marketedupdated 3mo ago
by $ANIP ANI PHARMACEUTICALS INC
Approved
community read0 votes

🐶 often sniffed alongside

top 8
  • drugtadalafil6 co-mentions · 6 sources
  • tagRecall6 co-mentions · 6 sources
  • drugAdcirca6 co-mentions · 6 sources
  • drugCelebrex4 co-mentions · 2 sources
  • drugcelecoxib SR4 co-mentions · 2 sources
  • drugElyxyb4 co-mentions · 2 sources
  • drugCELECOXIB4 co-mentions · 2 sources
  • companyAlembic Pharmaceuticals Inc3 co-mentions · 1 sources

all catalysts(0)

nothing on the calendar yet

Trials studying Chewtadzy

  • phase3Actual Use Trial of Tadalafil 5 mgcompletedn=2,212
  • phase3A Study Providing Treatment Access in Participants With Pulmonary Hypertension Completing a Parent Study and Having no Other Optionrecruitingn=280
  • phase3Clinical Study to Compare the Efficacy and Safety of Macitentan and Tadalafil Monotherapies With the Corresponding Fixed-dose Combination Therapy in Subjects With Pulmonary Arterial Hypertension (PAH)completedn=187
  • phase1Hezkue®, Hezkue Turbo®, and Commercial Sildenafil Products in Fed Healthy Male Subjectnot yet recruitingn=72
  • phase1A Study to Compare the Macitentan-tadalafil Fixed Dose Combination Tablet Relative to the Concomitant Administration of the Reference Tablets of Macitentan and Tadalafil in Healthy Subjectscompletedn=38
  • EP1Window of Opportunity Trial of Nivolumab and Tadalafil in Patients With Squamous Cell Carcinoma of the Head and Neckcompletedn=50
  • phase3The Efficacy and Safety of Initial Triple Versus Initial Dual Oral Combination Therapy in Patients With Newly Diagnosed Pulmonary Arterial Hypertensioncompletedn=247
  • phase1A Study of Fixed Dose Combination of Macitentan/Tadalafil (10 mg/20 mg) Compared to the Reference Free Combination of Macitentan and Tadalafil in Healthy Adult Participantscompletedn=40
more trials →

Patent cliff

source: FDA Orange Book
first barrier falls
Dec 24, 2038
~12.4 years out

Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.

patents (4)

  • Dec 24, 2038formulationUS 11382917
  • Dec 24, 2038formulationUS 11666576
  • Dec 24, 2038formulationUS 11975006
  • Dec 24, 2038formulationUS 12186322

News(0)

no news has mentioned this drug yet

brand
Chewtadzy
generic
tadalafil
indication
Storage Symptoms of Benign Prostatic Hyperplasia
phase
marketed
Data sources
ClinicalTrials.gov
last refreshed 14m ago
Found something off?
🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?